1. Home
  2. FFWM vs SLDB Comparison

FFWM vs SLDB Comparison

Compare FFWM & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Foundation Inc.

FFWM

First Foundation Inc.

HOLD

Current Price

$5.41

Market Cap

421.1M

Sector

Finance

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$5.16

Market Cap

464.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFWM
SLDB
Founded
1990
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.1M
464.1M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
FFWM
SLDB
Price
$5.41
$5.16
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$6.17
$14.70
AVG Volume (30 Days)
980.0K
1.3M
Earning Date
10-30-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$159,621,000.00
N/A
Revenue This Year
$164.76
N/A
Revenue Next Year
$10.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47.55
N/A
52 Week Low
$4.42
$2.41
52 Week High
$8.14
$7.37

Technical Indicators

Market Signals
Indicator
FFWM
SLDB
Relative Strength Index (RSI) 53.75 53.54
Support Level $5.04 $4.16
Resistance Level $5.52 $5.45
Average True Range (ATR) 0.20 0.40
MACD 0.06 0.15
Stochastic Oscillator 83.33 79.29

Price Performance

Historical Comparison
FFWM
SLDB

About FFWM First Foundation Inc.

First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: